OUTPATIENT ENDOVASCULAR & INTERVEN… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

GERALD NIEDZWIECKI MD

Phone

8885486347

Tax Period

2024-01-01 to 2024-12-31

OUTPATIENT ENDOVASCULAR & INTERVENTIONAL SOCIETY, founded in 2013, is a community nonprofit in the Diseases & Disorders sector that reported $1.2M in total revenue in fiscal year 2024. Revenue fell 30% from the prior year — a significant decline worth monitoring. Expenses of $1.3M exceeded revenue, resulting in a 15% operating deficit.

Mission

TO IMPROVE QUALITY HEALTH CARE BY ESTABLISHING PROFESSIONAL QUALITY STANDARDS FOR VASCULAR SURGERY AND INTERVENTIONAL SPECIALTIES AND PROVIDING THEM WITH SCIENTIFIC EDUCATION.

Program Service Accomplishments

Program 1

Expenses: $562,423

MEETINGS FOR DOCTORS IN THE SPECIALTIES

Program 2

Expenses: $188,359

OTHER EXEMPT PURPOSE ACTIVITIES

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $100,205

Program Service Revenue $1,006,035

Investment Income $39,520

Other Revenue $28,000

TOTAL REVENUE $1,173,760

Expense Breakdown

Grants Paid $0

Salaries & Benefits $274,463

Fundraising Expenses $0

Program Expenses $750,782

Other Expenses $1,070,145

TOTAL EXPENSES $1,344,608

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,173,760	$1,669,467	-0.3%
Expenses	$1,344,608	$1,307,091	+0.0%
Net Income	$-170,848	$362,376	-1.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PATRICK RYAN MD	President	5.00	Officer Director	$0	$0	$0
BOB TAHARA MD	PAST PRESIDENT	1.00	Director	$0	$0	$0
GERALD NIEDZWIECKI MD	Treasurer	5.00	Officer Director	$0	$0	$0
BRET WIECHMANN MD	Director	1.00	Director	$0	$0	$0
ERIC DIPPEL MD	Director	1.00	Director	$0	$0	$0
GEORGE ADAMS MD	Director	1.00	Director	$0	$0	$0
CURTIS ANDERSON MD	Director	1.00	Director	$0	$0	$0
STEPHEN DAUGHERTY MD	Director	1.00	Director	$0	$0	$0
ALEX DABOWIECKI MD	Director	1.00	Director	$0	$0	$0
KAVI DEVULAPALLI MD	Director	1.00	Director	$0	$0	$0
RAFAEL MALGOR MD	Director	1.00	Director	$0	$0	$0
PRADEEP NAIR MD	Director	1.00	Director	$0	$0	$0
FADI SAAB MD	PRES ELECT	5.00	Officer Director	$0	$0	$0
PAUL VAROSY MD	Director	1.00	Director	$0	$0	$0
MIKE WATTS MD	Director	1.00	Director	$0	$0	$0
BRIAN WHYTE MD	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,173,760	$1,344,608	$1,802,812	$-170,848
2023	$1,669,467	$1,307,091	$2,019,203	$362,376
2022	$1,341,390	$1,025,968	$1,724,566	$315,422
2021	$963,978	$770,444	$1,376,067	$193,534
2020	$877,611	$476,963	$1,146,793	$400,648
2019	$853,556	$559,538	$667,963	$294,018
2018	$534,388	$544,841	$400,990	$-10,453

OUTPATIENT ENDOVASCULAR & INTERVENTIONAL SOCIETY